4-113663655-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001321571.2(CAMK2D):c.161-1883A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.275 in 149,910 control chromosomes in the GnomAD database, including 6,532 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.27 ( 6532 hom., cov: 31)
Consequence
CAMK2D
NM_001321571.2 intron
NM_001321571.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.246
Publications
4 publications found
Genes affected
CAMK2D (HGNC:1462): (calcium/calmodulin dependent protein kinase II delta) The product of this gene belongs to the serine/threonine protein kinase family and to the Ca(2+)/calmodulin-dependent protein kinase subfamily. Calcium signaling is crucial for several aspects of plasticity at glutamatergic synapses. In mammalian cells, the enzyme is composed of four different chains: alpha, beta, gamma, and delta. The product of this gene is a delta chain. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Distinct isoforms of this chain have different expression patterns.[provided by RefSeq, Nov 2008]
CAMK2D Gene-Disease associations (from GenCC):
- CAMK2D-related neurodevelopmental disorder and dilated cardiomyopathyInheritance: AD Classification: MODERATE Submitted by: G2P
- complex neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.383 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.275 AC: 41236AN: 149880Hom.: 6539 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
41236
AN:
149880
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.275 AC: 41219AN: 149910Hom.: 6532 Cov.: 31 AF XY: 0.279 AC XY: 20432AN XY: 73154 show subpopulations
GnomAD4 genome
AF:
AC:
41219
AN:
149910
Hom.:
Cov.:
31
AF XY:
AC XY:
20432
AN XY:
73154
show subpopulations
African (AFR)
AF:
AC:
4892
AN:
41038
American (AMR)
AF:
AC:
4860
AN:
14998
Ashkenazi Jewish (ASJ)
AF:
AC:
1137
AN:
3460
East Asian (EAS)
AF:
AC:
1440
AN:
5142
South Asian (SAS)
AF:
AC:
1887
AN:
4748
European-Finnish (FIN)
AF:
AC:
3354
AN:
9680
Middle Eastern (MID)
AF:
AC:
69
AN:
286
European-Non Finnish (NFE)
AF:
AC:
22618
AN:
67582
Other (OTH)
AF:
AC:
566
AN:
2070
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1463
2926
4388
5851
7314
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
430
860
1290
1720
2150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1204
AN:
3450
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.